Prices delayed by at least 15 minutes | Print
West Pharmaceutical Services (WST)
EquityOpen
$360.01
Previous close
$360.43
Trade high
$362.16
Volume
511,933
Year high
$415.73
Year low
$310.42
Dividend yield
0.22%
Market capitalisation
$25.82 bn
P/E ratio
47.55
ISIN
US9553061055
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 24/04/2024 | 31/07/2024 |
| Ex-dividend date | 23/04/2024 | 31/07/2024 |
| Payment date | 01/05/2024 | 07/08/2024 |
| Amount | $0.2 | $0.2 |
Company profile
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.